Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis-Reference-Cited by-同舟云学术

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

Published:2022-10 Issue:10 Volume:28 Page:681-693
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Saliba Rima M.,Alousi Amin M.,Pidala Joseph,Arora Mukta,Spellman Stephen R.,Hemmer Michael T.,Wang Tao^ORCID,Abboud Camille^ORCID,Ahmed Sairah^ORCID,Antin Joseph H.^ORCID,Beitinjaneh Amer,Buchbinder David,Byrne Michael,Cahn Jean-Yves,Choe Hannah,Hanna Rabi^ORCID,Hematti Peiman^ORCID,Kamble Rammurti T.,Kitko Carrie L.^ORCID,Laughlin Mary,Lekakis Lazaros,MacMillan Margaret L.^ORCID,Martino Rodrigo^ORCID,Mehta Parinda A.,Nishihori Taiga,Patel Sagar S.^ORCID,Perales Miguel-Angel^ORCID,Rangarajan Hemalatha G.^ORCID,Ringdén Olov,Rosenthal Joseph,Savani Bipin N.^ORCID,Schultz Kirk R.^ORCID,Seo Sachiko,Teshima Takanori^ORCID,van der Poel Marjolein,Verdonck Leo F.^ORCID,Weisdorf Daniel^ORCID,Wirk Baldeep,Yared Jean A.^ORCID,Schriber Jeffrey,Champlin Richard E.,Ciurea Stefan O.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference48 articles.

1. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation;Luznik;Immunol Res,2010

2. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT;Ruggeri;J Hematol Oncol,2018

3. Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application;El Fakih;Bone Marrow Transplant,2020

4. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation;Mielcarek;Blood,2016

5. Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning;Kanakry;J Clin Oncol,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation;European Journal of Haematology;2024-08-18

2. Associations between acute and chronic graft-versus-host disease;Blood Advances;2024-08-14

3. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD;Blood Advances;2024-06-14

4. Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2024-06-10

5. Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH);PLOS ONE;2024-05-16